Sumitomo Mitsui Asset Management Company LTD maintained its stake in shares of Core Laboratories N.V. (NYSE:CLB) during the second quarter, Holdings Channel reports. The institutional investor owned 3,684 shares of the oil and gas company’s stock at the end of the second quarter. Sumitomo Mitsui Asset Management Company LTD’s holdings in Core Laboratories N.V. were worth $373,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Parallel Advisors LLC raised its position in Core Laboratories N.V. by 33.4% in the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock worth $101,000 after buying an additional 223 shares during the last quarter. Quantbot Technologies LP bought a new position in Core Laboratories N.V. during the first quarter worth $106,000. Advisory Services Network LLC bought a new position in Core Laboratories N.V. during the first quarter worth $118,000. FNY Managed Accounts LLC bought a new position in Core Laboratories N.V. during the first quarter worth $123,000. Finally, First Bank & Trust raised its position in Core Laboratories N.V. by 2.7% in the first quarter. First Bank & Trust now owns 1,411 shares of the oil and gas company’s stock worth $163,000 after buying an additional 37 shares during the last quarter.

Core Laboratories N.V. (CLB) opened at 92.92 on Friday. Core Laboratories N.V. has a 52 week low of $92.81 and a 52 week high of $125.83. The company has a 50 day moving average price of $101.46 and a 200 day moving average price of $108.84. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 57.01 and a beta of 1.60.

Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings data on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.51 by $0.01. The business had revenue of $163.90 million during the quarter, compared to the consensus estimate of $168.23 million. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. Core Laboratories N.V.’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.35 EPS. Analysts expect that Core Laboratories N.V. will post $2.09 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 14th. Investors of record on Monday, July 17th will be issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 2.37%. The ex-dividend date is Thursday, July 13th. Core Laboratories N.V.’s dividend payout ratio is currently 134.15%.

TRADEMARK VIOLATION NOTICE: “Core Laboratories N.V. (NYSE:CLB) Position Held by Sumitomo Mitsui Asset Management Company LTD” was first posted by Daily Political and is owned by of Daily Political. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/12/core-laboratories-n-v-nyseclb-position-held-by-sumitomo-mitsui-asset-management-company-ltd.html.

A number of equities analysts have weighed in on CLB shares. Royal Bank Of Canada set a $145.00 price objective on Core Laboratories N.V. and gave the company a “buy” rating in a research note on Saturday, June 17th. Zacks Investment Research upgraded Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $116.00 price objective for the company in a research note on Monday, June 12th. Loop Capital upgraded Core Laboratories N.V. from a “hold” rating to a “buy” rating and lifted their price objective for the company from $125.00 to $130.00 in a research note on Friday, April 21st. BidaskClub upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Wednesday, July 5th. Finally, Scotiabank set a $136.00 price objective on Core Laboratories N.V. and gave the company a “hold” rating in a research note on Saturday, April 22nd. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company. Core Laboratories N.V. presently has a consensus rating of “Hold” and a consensus price target of $117.17.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.